| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| LOP(L) | 97 | 71.3% | 0.34 | 123 | 96.1% |
| SPS(R) | 20 | 14.7% | -inf | 0 | 0.0% |
| ICL(L) | 14 | 10.3% | -inf | 0 | 0.0% |
| Optic-unspecified(L) | 0 | 0.0% | inf | 4 | 3.1% |
| IB | 3 | 2.2% | -inf | 0 | 0.0% |
| CentralBrain-unspecified | 2 | 1.5% | -inf | 0 | 0.0% |
| PLP(L) | 0 | 0.0% | inf | 1 | 0.8% |
| upstream partner | # | NT | conns LopVC_unclear | % In | CV |
|---|---|---|---|---|---|
| T4a (L) | 8 | ACh | 14 | 11.2% | 0.4 |
| T4c (L) | 7 | ACh | 13 | 10.4% | 0.5 |
| T5c (L) | 4 | ACh | 8 | 6.4% | 0.6 |
| TmY20 (L) | 5 | ACh | 7 | 5.6% | 0.6 |
| TmY9b (L) | 3 | ACh | 7 | 5.6% | 0.2 |
| SLP003 (L) | 1 | GABA | 5 | 4.0% | 0.0 |
| LPT53 (L) | 1 | GABA | 5 | 4.0% | 0.0 |
| GNG504 (R) | 1 | GABA | 4 | 3.2% | 0.0 |
| LPT23 (L) | 1 | ACh | 3 | 2.4% | 0.0 |
| GNG286 (L) | 1 | ACh | 3 | 2.4% | 0.0 |
| Tlp14 (L) | 2 | Glu | 3 | 2.4% | 0.3 |
| T5b (L) | 3 | ACh | 3 | 2.4% | 0.0 |
| Y11 (L) | 3 | Glu | 3 | 2.4% | 0.0 |
| T4b (L) | 3 | ACh | 3 | 2.4% | 0.0 |
| T5a (L) | 3 | ACh | 3 | 2.4% | 0.0 |
| TmY10 (L) | 1 | ACh | 2 | 1.6% | 0.0 |
| PS238 (L) | 1 | ACh | 2 | 1.6% | 0.0 |
| CB1541 (L) | 1 | ACh | 2 | 1.6% | 0.0 |
| LPi3412 (L) | 1 | Glu | 2 | 1.6% | 0.0 |
| IB044 (L) | 1 | ACh | 2 | 1.6% | 0.0 |
| LPC1 (L) | 1 | ACh | 2 | 1.6% | 0.0 |
| IB097 (L) | 1 | Glu | 2 | 1.6% | 0.0 |
| SLP004 (L) | 1 | GABA | 2 | 1.6% | 0.0 |
| T2 (L) | 2 | ACh | 2 | 1.6% | 0.0 |
| TmY17 (L) | 2 | ACh | 2 | 1.6% | 0.0 |
| Y3 (L) | 2 | ACh | 2 | 1.6% | 0.0 |
| DNb04 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| PS300 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| LOLP1 (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| Y12 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| LoVP32 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| CB1227 (R) | 1 | Glu | 1 | 0.8% | 0.0 |
| LoVP69 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| SMP397 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| PLP150 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| LPi2c (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| PLP001 (R) | 1 | GABA | 1 | 0.8% | 0.0 |
| PLP001 (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| LPLC1 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| VES108 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| LoVC22 (R) | 1 | DA | 1 | 0.8% | 0.0 |
| LoVCLo3 (L) | 1 | OA | 1 | 0.8% | 0.0 |
| MeVPOL1 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| 5-HTPMPV03 (R) | 1 | 5-HT | 1 | 0.8% | 0.0 |
| DNp27 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| downstream partner | # | NT | conns LopVC_unclear | % Out | CV |
|---|---|---|---|---|---|
| Y11 (L) | 7 | Glu | 71 | 19.8% | 0.7 |
| Y13 (L) | 14 | Glu | 66 | 18.4% | 0.5 |
| TmY17 (L) | 13 | ACh | 56 | 15.6% | 0.7 |
| TmY20 (L) | 12 | ACh | 50 | 14.0% | 0.8 |
| TmY10 (L) | 6 | ACh | 17 | 4.7% | 0.5 |
| LPT50 (L) | 1 | GABA | 10 | 2.8% | 0.0 |
| H1 (L) | 1 | Glu | 9 | 2.5% | 0.0 |
| Tlp13 (L) | 1 | Glu | 7 | 2.0% | 0.0 |
| dCal1 (L) | 1 | GABA | 7 | 2.0% | 0.0 |
| Tlp11 (L) | 2 | Glu | 6 | 1.7% | 0.7 |
| LLPC3 (L) | 3 | ACh | 6 | 1.7% | 0.4 |
| vCal1 (L) | 1 | Glu | 4 | 1.1% | 0.0 |
| LPi2e (L) | 2 | Glu | 4 | 1.1% | 0.0 |
| T5b (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| T5d (L) | 2 | ACh | 3 | 0.8% | 0.3 |
| LLPC1 (L) | 2 | ACh | 3 | 0.8% | 0.3 |
| TmY5a (L) | 2 | Glu | 3 | 0.8% | 0.3 |
| Y3 (L) | 3 | ACh | 3 | 0.8% | 0.0 |
| Tm4 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| T4b (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| T4a (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| LPi2d (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| Y14 (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| Tm16 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| LPi34 (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| H2 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| T4c (L) | 2 | ACh | 2 | 0.6% | 0.0 |
| TmY18 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| Tm3 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LPi14 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| T5a (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| TmY13 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| TmY4 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| Y12 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LPi2c (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LPLC2 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LPT31 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| TmY21 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| WED184 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
